The first meta-analysis of clinical data sets aimed to identify new cancer/testis genes and investigate the expression profiles of human meiotic genes in normal and cancer tissues and cell lines; several highly specific cancer biomarker genes, including PRDM9, were recognized as genes with oncogenic characteristics [154]. Here, PRDM9 is linked to cancer.